Lunai Bioworks Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Cash and Cash Equivalents Quarterly3.2M
Quarterly Service Revenue Quarterly20.9K
Quarterly Net Loss Quarterly-2.6M
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Below $1.00 per share for 30 consecutive business daysAction: Implement reverse stock split (authorized range of 1-for-3 to 1-for-30) to lift share price and maintain listing.
- Nasdaq Minimum Stockholders' Equity RequirementTrigger: Below $2.5 million minimum required by Nasdaq Listing Rule 5550(b)(1)Action: Monitor Hearings Panel formal determination of compliance following the $20 million preferred equity issuance.
- Naked Short Selling Litigation ProgressTrigger: Expedited discovery phase in the U.S. District Court for the District of DelawareAction: Identify 'John Doe' defendants and pursue legal remedies to protect shareholder value.
Research as of 20 Jun 2026